# 2026年2月12日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 大型腹部手术中的个体化围手术期血压管理——答复

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41670961)
**期刊：** JAMA
**PMID：** 41670961
**DOI：** 10.1001/jama.2025.25542

### 第一部分 原文与翻译

**英文原标题：** Individualized Perioperative Blood Pressure Management in Major Abdominal Surgery-Reply.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

该文献是针对大型腹部手术个体化围手术期血压管理相关研究的作者回信。此类回复通常针对同行评议或读者提问，对研究的方法论、血压基准值的设定以及临床结局的因果推断进行进一步澄清。尽管不包含正式摘要，但其内容对于深入理解大型临床试验的实施细节及围手术期血流动力学优化的争议点具有重要的补充参考价值，体现了学术界对精准术中管理的持续关注。

---

## 2. 心脏手术后肺炎的术前和术中危险因素：STERNOCAT（胸骨切开术心脏手术导管结局）随机对照试验的辅助研究及系统评价与荟萃分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41670402)
**期刊：** Critical care medicine
**PMID：** 41670402
**DOI：** 10.1097/CCM.0000000000007060

### 第一部分 原文与翻译

**英文原标题：** Preoperative and Intraoperative Risk Factors for Postoperative Pneumonia After Cardiac Surgery: An Ancillary Study of the STERNOCAT (Catheter Outcomes With Sternotomy Cardiac Operated) Randomized Trial and a Systematic Review With Meta-Analysis.

> **英文摘要：**
> OBJECTIVE: Postoperative pneumonia (POP) is a frequent complication after cardiac surgery, which significantly worsens prognosis. This study aimed to identify preoperative and intraoperative factors independently associated with POP in a cardiac surgery cohort, perform a systematic review (SR) and meta-analysis of risk factors, outcomes, and predictive models, and validate these models in the cohort.
> 
> DESIGN: This is an ancillary study of the STERNOCAT (Catheter Outcomes With Sternotomy Cardiac Operated) trial completed by an SR and meta-analysis. PubMed, Embase, and Cochrane Library were searched (January 2000 to March 31, 2025). Two reviewers independently screened references to identify studies on adult cardiac surgery patients assessing POP risk factors or predictive models, extracted data, and assessed methodological quality. Predictive models identified through the SR were externally validated using the STERNOCAT cohort.
> 
> SETTING: Cardiac surgery units in France (STERNOCAT cohort) and international hospital settings (SR studies).
> 
> PATIENTS: A total of 1,470 patients from the STERNOCAT cohort and 172,079 from 24 studies overall were included in the SR.
> 
> INTERVENTIONS: None.
> 
> MEASUREMENTS AND MAIN RESULTS: In the STERNOCAT ancillary study, 78 of 1470 patients developed POP (5.3%). Independent risk factors included ischemic cardiomyopathy (odds ratio [OR] 1.89, 95% CI [1.13-3.16]), cardiopulmonary bypass (CPB) duration (OR 1.10, 95% CI [1.02-1.18]), and catecholamine use (OR 4.07, 95% CI [2.45-6.76]). POP was associated with higher 30-day mortality (14.1% vs. 1.5%, p < 0.0001). The meta-analysis identified 14 significant risk factors for POP. Of these, 10 were non-modifiable (e.g., age, diabetes mellitus, chronic obstructive pulmonary disease, chronic renal disease, previous cardiac surgery, emergency surgery). Four were partially modifiable: active smoking, CPB duration, intraoperative transfusions (presence and amount). Only one model, limited to preoperative variables, could be externally validated and showed poor accuracy.
> 
> CONCLUSIONS: This study highlights the difficulty of predicting and preventing POP, as most identified risk factors are non-modifiable or require long-term preventive strategies. Perioperative optimization, particularly regarding CPB management and transfusion practices, therefore, remains essential to improving patient outcomes.
> 
> REGISTRATION: PROSPERO (CRD42024555519).

> **中文摘要：**
> 目的：术后肺炎（POP）是心脏手术后常见的并发症，会显著恶化预后。本研究旨在确定心脏手术队列中与 POP 独立相关的术前和术中因素，对风险因素、结局和预测模型进行系统评价（SR）和荟萃分析，并在该队列中验证这些模型。
> 
> 设计：这是一项基于 STERNOCAT（胸骨切开术心脏手术导管结局）试验的辅助研究，并辅以系统评价和荟萃分析。检索了 PubMed、Embase 和 Cochrane 图书馆（2000 年 1 月至 2025 年 3 月 31 日）。两名评审员独立筛选文献，以确定评估成年心脏手术患者 POP 风险因素或预测模型的研究，提取数据并评估方法学质量。通过系统评价确定的预测模型使用 STERNOCAT 队列进行了外部验证。
> 
> 地点：法国的心脏外科中心（STERNOCAT 队列）和国际医院环境（系统评价纳入的研究）。
> 
> 患者：STERNOCAT 队列共纳入 1,470 名患者，系统评价共纳入 24 项研究，涉及 172,079 名患者。
> 
> 干预措施：无。
> 
> 测量指标及主要结果：在 STERNOCAT 辅助研究中，1,470 名患者中有 78 名（5.3%）发生了 POP。独立危险因素包括缺血性心肌病（比值比 [OR] 1.89，95% CI [1.13-3.16]）、体外循环（CPB）持续时间（OR 1.10，95% CI [1.02-1.18]）和儿茶酚胺的使用（OR 4.07，95% CI [2.45-6.76]）。POP 与较高的 30 天死亡率显著相关（14.1% vs. 1.5%，p < 0.0001）。荟萃分析确定了 14 个 POP 的显著危险因素。其中 10 个为不可干预因素（如年龄、糖尿病、慢性阻塞性肺疾病、慢性肾病、既往心脏手术、急诊手术）。4 个为部分可干预因素：主动吸烟、CPB 持续时间、术中输血（是否存在及输血量）。在确定的预测模型中，仅有一个仅包含术前变量的模型能进行外部验证，但其准确性较差。
> 
> 结论：本研究强调了预测和预防 POP 的难度，因为大多数确定的危险因素是不可调节的，或者需要长期的预防策略。因此，围手术期优化（特别是关于 CPB 管理和输血实践）对于改善患者预后仍然至关重要。
> 
> 注册号：PROSPERO (CRD42024555519)。

### 第二部分 AI 大师评价

该研究结合了前瞻性随机对照试验的辅助研究与大规模系统评价/荟萃分析，深入探讨了心脏手术后肺炎（POP）的风险因素及现有预测模型的临床价值。研究发现 POP 发生率约为 5.3% 且与死亡率密切相关，但关键发现在于多数风险因素（如高龄、合并症）难以在围手术期通过医疗手段干预。研究的创新性在于通过外部验证揭示了现有 POP 预测模型的普遍低效性，并明确指出优化体外循环时间和规范输血管理是临床少数可行的干预路径。这项工作不仅量化了 POP 的预后影响，更为心脏外科围手术期精细化管理提供了重要的循证支持。

---

## 3. 针对重症患者腹腔念珠菌病的菌种特异性定量PCR分析性能：一项基于pBDG2多中心研究的概念验证性事后分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41668159)
**期刊：** Critical care (London, England)
**PMID：** 41668159
**DOI：** 10.1186/s13054-026-05882-5

### 第一部分 原文与翻译

**英文原标题：** Analytical performance of species-targeted quantitative PCR for intra-abdominal candidiasis in critically ill patients: a proof-of-concept post hoc analysis from the pBDG2 multicenter study.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本研究聚焦于重症患者腹腔念珠菌病（IAC）的快速诊断，对菌种特异性定量PCR（qPCR）的分析性能进行了系统评估。作为pBDG2多中心研究的事后分析，该研究成功验证了分子诊断技术在复杂腹腔感染中快速鉴定念珠菌菌种的可行性，具有显著的临床应用潜力。其局限性在于事后分析的本质，但其提供的概念验证数据为未来优化重症真菌感染的早期诊断和靶向治疗策略提供了坚实的证据基础。

---

## 4. IL-4-STAT6信号通过拮抗IL-18感知延迟保护性CD8 T细胞旁路激活

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41667619)
**期刊：** Nature immunology
**PMID：** 41667619
**DOI：** 10.1038/s41590-026-02430-9

### 第一部分 原文与翻译

**英文原标题：** IL-4-STAT6 signaling delays protective CD8 T cell bystander activation by antagonizing IL-18 sensing.

> **英文摘要：**
> Memory CD8 T (T) cells are activated into innate-like killers by cytokines, including interleukin-12 (IL-12), IL-15 and IL-18; but mechanisms regulating this phenomenon (termed bystander activation) are unclear. Here we show that basal IL-4 signals antagonize IL-18 sensing and subsequent interferon-γ production during T cell bystander activation. IL-4 treatment can act directly on T cells in a STAT6-dependent manner to limit interferon-γ-mediated control of a bystander bacterial infection. IL-4 does not simply block bystander activation but tunes effector molecule expression. Strain-specific defects in bystander activation of homeostatic T cells partially relates to IL-4 exposure, but these differences are erased in T cells produced by T cell antigen receptor activation, leading to uniform IL-18 receptor expression and capacity for bystander activation/cytotoxicity. Our data demonstrate that bystander activation by inflammatory cytokines is subject to regulation by both IL-4 and prior antigen experience. These findings underscore the importance of the cytokine milieu in dictating bystander-mediated pathogen control.

> **中文摘要：**
> 记忆性CD8 T（Tmem）细胞可被包括白细胞介素-12（IL-12）、IL-15和IL-18在内的细胞因子激活为类先天性杀伤细胞；但调节这一现象（称为旁路激活）的机制尚不明确。在此，我们展示了基础IL-4信号在T细胞旁路激活过程中拮抗IL-18感知及随后的干扰素-γ产生。IL-4处理能以STAT6依赖的方式直接作用于T细胞，从而限制干扰素-γ介导的对旁路细菌感染的控制。IL-4并非简单地阻断旁路激活，而是调节效应分子的表达。稳态T细胞在旁路激活中的品系特异性缺陷部分与IL-4暴露有关，但在通过T细胞抗原受体激活产生的T细胞中，这些差异被消除，从而导致统一的IL-18受体表达以及旁路激活/细胞毒性能力。我们的数据表明，炎症细胞因子诱导的旁路激活受IL-4和既往抗原经验的双重调节。这些发现强调了细胞因子环境在决定旁路激活介导的病原体控制中的重要性。

### 第二部分 AI 大师评价

本研究揭示了IL-4-STAT6信号轴在调节CD8 T细胞旁路激活中的关键制动作用。通过实验证明，IL-4通过拮抗IL-18感知，以STAT6依赖的方式精细调控T细胞的效应分子表达，而非简单的功能阻断。研究进一步阐明了细胞因子微环境与既往抗原经验如何共同决定旁路激活的强度，为理解非特异性抗感染免疫的异质性提供了重要机制见解，具有显著的免疫生物学创新价值。

---

## 5. 洛铂联合氟尿嘧啶与顺铂联合氟尿嘧啶诱导化疗序贯同期放化疗治疗鼻咽癌的最终生存分析：一项多中心、随机、3期临床试验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41667463)
**期刊：** Nature communications
**PMID：** 41667463
**DOI：** 10.1038/s41467-026-69315-1

### 第一部分 原文与翻译

**英文原标题：** Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial.

> **英文摘要：**
> In nasopharyngeal carcinoma, cisplatin is known to be associated with poor treatment compliance and notable side effects. More effective and safer platinum drugs are needed for the treatment of patients with nasopharyngeal carcinoma. In 2021, our multicenter, randomized, phase 3 trial reported that lobaplatin and fluorouracil induction chemotherapy plus concurrent chemoradiotherapy resulted in non-inferior survival and fewer toxic effects than did cisplatin-based therapy in nasopharyngeal carcinoma. Data from the 10-year survival analysis are updated here. With a median follow-up of 10.6 years in the intention-to-treat population, 10-year progression-free survival is 70.7% in the lobaplatin-based therapy group vs. 71.9% in the cisplatin-based therapy group (HR 1.02, 95% CI 0.72-1.43; log-rank p = 0.885). The difference between the groups is 1.2% (95% CI -6.7-9.1, p = 0.015), which is lower than the prespecified non-inferiority margin of 10%. The results are similar when we analyze patients in the per-protocol population. In the univariable and multivariable analyses, stage is an independent prognostic factor for progression-free survival (p = 0.001). The subgroup analyses suggest that the non-inferiority of lobaplatin-based therapy did not differ among specific populations. The incidence of late toxic effects is similar between the therapy groups, except for grades 1-2 peripheral neuropathy (p = 0.033), grades 1-2 deafness/otitis (p = 0.021), and grades 1-2/3 nephrotoxicity (p = 0.005; p = 0.021), the incidence of which is greater in the cisplatin-based therapy group than in the lobaplatin-based therapy group. Our findings suggest that lobaplatin and fluorouracil induction chemotherapy plus lobaplatin-based concurrent chemoradiotherapy is an alternative doublet treatment strategy to cisplatin-based concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

> **中文摘要：**
> 在鼻咽癌中，已知顺铂与较差的治疗依从性和显著的副作用相关。鼻咽癌患者的治疗需要更有效且更安全的铂类药物。2021年，我们的多中心、随机、3期临床试验报告称，在鼻咽癌中，洛铂联合氟尿嘧啶诱导化疗加同期放化疗产生的生存获益不劣于顺铂方案，且毒副反应更少。本文更新了10年生存分析的数据。在意向性治疗人群中，中位随访时间为10.6年，洛铂治疗组的10年无进展生存率为70.7%，而顺铂治疗组为71.9%（HR 1.02, 95% CI 0.72-1.43; log-rank p = 0.885）。两组间的差异为1.2%（95% CI -6.7-9.1, p = 0.015），低于预设的10%非劣效性界值。对符合方案人群进行分析时，结果相似。在单变量和多变量分析中，分期是无进展生存期的独立预后因素（p = 0.001）。亚组分析表明，洛铂治疗的非劣效性在特定人群中没有差异。两组晚期毒副反应的发生率相似，但1-2级周围神经病变（p = 0.033）、1-2级耳聋/中耳炎（p = 0.021）以及1-2/3级肾毒性（p = 0.005; p = 0.021）除外，顺铂治疗组的这些反应发生率高于洛铂治疗组。我们的研究结果表明，洛铂联合氟尿嘧啶诱导化疗加基于洛铂的同期放化疗是局部晚期鼻咽癌患者替代顺铂同期放化疗的一种可选的双药治疗策略。

### 第二部分 AI 大师评价

该项多中心3期临床试验提供了长达10.6年的长期随访数据，有力证实了洛铂联合氟尿嘧啶方案在局部晚期鼻咽癌治疗中的非劣效性。研究显示，洛铂方案在维持与顺铂相当的10年无进展生存率的同时，显著降低了周围神经病变、耳毒性及肾毒性等严重影响生活质量的晚期毒副反应。这一长周期的循证证据为临床医生提供了重要的参考，使洛铂成为无法耐受顺铂毒性患者的可靠替代选择，具有极高的临床应用价值。

---

## 6. 生态分区实现了人类假单胞菌感染中噬菌体与抗生素的协作

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41667461)
**期刊：** Nature communications
**PMID：** 41667461
**DOI：** 10.1038/s41467-026-69247-w

### 第一部分 原文与翻译

**英文原标题：** Ecological partitioning enables phage-antibiotic cooperation in a human Pseudomonas infection.

> **英文摘要：**
> Bacteriophage-antibiotic coadministration is increasingly used for refractory infections, yet the in vivo interactions among phages, bacteria, antibiotics, and host immunity remain poorly defined. We report a longitudinal, multiomic case analysis of a male in his seventies with cystic fibrosis (CF) experiencing an acute-on-chronic pulmonary exacerbation caused by multidrug-resistant (MDR) Pseudomonas aeruginosa. After colistin discontinuation due to nephrotoxicity, ciprofloxacin was initiated, with an intravenous two-phage cocktail introduced days later. Distinct mucoid and nonmucoid bacterial subpopulations associated differentially with antibiotic versus phage exposure, consistent with nonoverlapping selective pressures. Phage activity was temporally constrained, with one phage dominating early bacterial and genomic signals before attenuating after approximately seven days, despite continued genomic detectability. In contrast, the second phage showed no evidence of productive activity. This asymmetry coincided with phage-reactive humoral immunity: pre-existing IgM was associated with lack of recoverability of one phage, while treatment-associated IgM emergence temporally tracked attenuation of the dominant phage. Although phage-resistant variants arose during therapy, they showed limited expansion relative to susceptible populations. These findings define a mechanistic framework-chemobiotherapy-in which chemical and biological antimicrobials coordinate through ecological and immunologic complementarity rather than direct pharmacologic synergy.

> **中文摘要：**
> 噬菌体与抗生素联合给药越来越多地用于治疗难治性感染，但噬菌体、细菌、抗生素和宿主免疫在体内的相互作用仍不明确。我们报告了一例 70 多岁患有囊性纤维化 (CF) 的男性患者的纵向、多组学案例分析，该患者经历了由多重耐药 (MDR) 铜绿假单胞菌引起的慢性肺部疾病急性加重。在因肾毒性停用多粘菌素后，患者开始使用环丙沙星，并在几天后引入了静脉注射的双噬菌体鸡尾酒疗法。不同的粘液型和非粘液型细菌亚群与抗生素和噬菌体暴露表现出不同的关联，这与非重叠的选择压力一致。噬菌体活性受到时间限制，其中一种噬菌体在早期细菌和基因组信号中占主导地位，但在约七天后减弱，尽管在基因组上仍可检测到其存在。相比之下，第二种噬菌体没有表现出产生有效活性的证据。这种不对称性与噬菌体反应性体液免疫相吻合：预先存在的 IgM 与一种噬菌体无法回收有关，而治疗相关的 IgM 出现则在时间上追踪了主导噬菌体的活性衰减。虽然治疗期间出现了耐噬菌体变异株，但与敏感种群相比，它们的扩张有限。这些发现定义了一个机制框架——化学-生物疗法（chemobiotherapy），其中化学抗菌药物和生物抗菌药物通过生态和免疫互补而非直接的药理协同作用进行协调。

### 第二部分 AI 大师评价

该研究通过对一名囊性纤维化患者的纵向多组学分析，深入探讨了噬菌体-抗生素联合治疗多重耐药铜绿假单胞菌感染的体内动态。研究创新性地提出了“化学-生物疗法”概念，证明了两者并非通过简单的药理协同，而是通过针对不同细菌亚群的生态分区以及受宿主 IgM 免疫反应调控的时间动态来实现互补。这一发现强调了宿主免疫对噬菌体疗法有效性的关键影响，为未来设计精准的个体化抗菌治疗方案提供了重要理论支撑。

---

## 7. 病原体载量的变异及其与感染力之间的关系拓宽了禽疟疾的分布范围

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41667434)
**期刊：** Nature communications
**PMID：** 41667434
**DOI：** 10.1038/s41467-026-68927-x

### 第一部分 原文与翻译

**英文原标题：** Variation in pathogen load and the pathogen load-infectiousness relationship broaden avian malaria's distribution.

> **英文摘要：**
> Two aspects of host infectiousness shape pathogen transmission and distribution but are underappreciated: the relationship between pathogen load and infectiousness, and variability in pathogen load within species. We quantified the relationship between host pathogen load (parasitemia) for avian malaria (Plasmodium relictum) and infectiousness for biting Culex quinquefasciatus mosquitoes with experimental infections in canaries (Serinus canaria). Using this relationship, we estimated the infectiousness of 17 bird species in 11 communities in Hawai'i and quantified the relative contributions of infection stage (acute versus chronic) to transmission. We show that infectiousness to mosquitoes increased with parasitemia, temperature, and time since feeding. The relationship's gradual (low) parasitemia slope resulted in a wide range of parasitemias being partly infectious, and high within-host species variability in parasitemia led to extensive overlap in infectiousness among hosts. Disproportionate mosquito host utilization (inferred from relative infection prevalence) elevated the importance of a few host species, yet broad overlap in species infectiousness resulted in similar total infectiousness across most bird communities. This similarity likely contributed to avian malaria's widespread distribution throughout Hawai'i despite diverse host community assemblages. Our findings highlight the importance of both the shape of the pathogen load-infectiousness relationship and within-species variability in determining a pathogen's host range, transmission intensity, and spatial spread.

> **中文摘要：**
> 宿主感染力的两个方面塑造了病原体的传播和分布，但尚未得到充分重视：即病原体载量与感染力之间的关系，以及物种内病原体载量的变异性。我们通过对金丝雀（Serinus canaria）进行实验性感染，量化了禽疟疾（Plasmodium relictum）宿主病原体载量（寄生虫血症）与对叮咬的致倦库蚊（Culex quinquefasciatus）感染力之间的关系。利用这一关系，我们估算了夏威夷11个群落中17种鸟类的感染力，并量化了感染阶段（急性与慢性）对传播的相对贡献。我们研究表明，对蚊子的感染力随寄生虫血症、温度和摄食后时间的增加而增加。该关系中较为平缓（低）的寄生虫血症斜率导致广泛的寄生虫血症范围具有部分感染力，而宿主物种内寄生虫血症的高度变异性导致不同宿主之间感染力的广泛重叠。蚊子对宿主的不成比例利用（根据相对感染流行率推断）提升了少数宿主物种的重要性，然而物种感染力的广泛重叠导致大多数鸟类群落的总感染力相似。尽管宿主群落组合多种多样，但这种相似性可能促成了禽疟疾在整个夏威夷的广泛分布。我们的研究结果强调了病原体载量与感染力关系的形状以及物种内变异在确定病原体宿主范围、传播强度和空间扩散方面的重要性。

### 第二部分 AI 大师评价

该研究通过实验感染与野外生态数据相结合，深入探讨了禽疟疾在夏威夷跨物种传播的机制。研究核心发现，病原体载量与感染力之间平缓的响应曲线以及显著的种内变异，使得不同宿主群落的总感染力趋于一致。这一机制解释了为何禽疟疾能在宿主组成高度多样化的生态系统中广泛扩散，为理解多宿主病原体的流行病学动态提供了重要视角。

---

速递结束，祝您工作愉快！